Ion Beam Applications SA

Research Ion Beam Applications SA (IBAB) on Bullrun: market cap EUR 491.36M, P/E 40.3, dividend yield 1.5%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerIBAB
• ExchangeBR
• CountryBelgium
• SectorHealthcare
• IndustryMedical Devices
• CurrencyEUR
• Market capEUR 491.36M
• P/E40.3
• Dividend yield1.5%
• Financial periodFY2025
• RevenueEUR 620.18M
• Revenue growth24.5%
• Net incomeEUR 12.73M
• Free cash flow-EUR 34.99M
• Gross margin32.2%

Valuation Snapshot

latest market cap is EUR 491.36M; P/E is 40.3; dividend yield is 1.5%.

About Ion Beam Applications SA

Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments, serious illnesses, and industrial applications in Belgium, the United States, China, Germany, and India. It operates through four segments, Clinical Proton Therapy; Clinical Dosimetry; IBA Technologies; and IBA Corporate. The company develops ConformalFLASH, a novel technique using the proton Bragg peak;

Frequently asked questions

What is Ion Beam Applications SA's market cap?

Ion Beam Applications SA's market capitalization is EUR 491.36M.

What is Ion Beam Applications SA's P/E ratio?

Ion Beam Applications SA's price-to-earnings (P/E) ratio is 40.3.

Does Ion Beam Applications SA pay a dividend?

Ion Beam Applications SA has a dividend yield of 1.5%.

What does Ion Beam Applications SA do?

Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments, serious illnesses, and industrial applications in Belgium, the United States, China, Germany, and India. It operates through four segments, Clinical Proton Therapy; Clinical Dosimetry;